tbuckley/cabot-search huggingface dataset:
GW27-e0348 Long Term Comparison between Novel Fully Bioresorbable Scaffolds and Drug-Eluting Stents: A Twenty-Four-Month Study in Porcine Coronary Arteries
Authors: Gaoke Feng, Jianmin Xiao, Chaoshi Qin, Zhao Lu, Jun Li, Xiaoxin Zheng, Shuzhong Liu, Tim Wu, Xuejun Jiang
Journal: Journal of the American College of Cardiology (2016)
Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci
Authors: Susan Slager, Kari Rabe, Sara Achenbach, Celine Vachon, Lynn Goldin, Sara Strom, Mark C Lanasa, Logan G. Spector, Laura Z Rassenti, Jose Leis, Nicola Camp, Martha Glenn, Neil E. Kay, Julie M Cunningham, Curtis A. Hanson, Gerald E Marti, J. Brice Weinberg, Vicki A. Morrison, Brian Link, Timothy Call, Neil Caporaso, James Cerhan
Journal: Blood (2010)
A Decade of Nilotinib and Dasatinib: From <i>In Vitro</i> Studies to First-Line Tyrosine Kinase Inhibitors
Authors: Thomas O'Hare
Journal: Cancer Research (2016)

See related article by O'Hare et al., [Cancer Res 2005;65:4500–5][1] .

In the Wasatch Mountains of Utah, there are many remarkable rock climbing routes. Leading the first ascent of a previously unclimbed route is respected for the accomplishment it signifies and the risk taking that it requires.
Risk for Intracerebral Hematoma Expansion—More Than Just the Spot Sign
Authors: Eric E. Smith
Journal: JAMA Neurology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
TCT-200 ECMO for hemodynamic support in patients with profound cardiogenic shock: experience and outcomes from a large single center
Authors: Angelo Nascimbene, Igor Banjac, Lisa Janowiak, Bindu Akkanti, Farshad Raissi Shabari, Indranee Rajapreyar, Rahat Hussain, Sriram Nathan, Pranav Loyalka, Igor Gregoric, Biswajit O. Kar
Journal: Journal of the American College of Cardiology (2015)
TCT-369 Correlation of Cardiovascular Risk Factors, Angina Patterns and Intravascular Ultrasound Findings: Largest Contemporary Characterization of Target Lesions
Authors: Carlos M. Campos, Hector M. Garcia-Garcia, Pannipa Suwannasom, Maik J. Grundeken, Yoshinobu Onuma, Luc Wasungu, Susan Veldhof, Patrick W. Serruys
Journal: Journal of the American College of Cardiology (2015)
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy
Authors: G L Uy, E J Duncavage, G S Chang, M A Jacoby, C A Miller, J Shao, S Heath, K Elliott, T Reineck, R S Fulton, C C Fronick, M O'Laughlin, L Ganel, C N Abboud, A F Cashen, J F DiPersio, R K Wilson, D C Link, J S Welch, T J Ley, T A Graubert, P Westervelt, M J Walter
Journal: Leukemia (2016)
TCT-96 Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study
Authors: G Michael Deeb, Stanley J. Chetcuti, Tanvir Bajwa, Daniel O'Hair, Harold L. Dauerman, Joseph D. Schmoker, Jeffrey Popma, Kamal R. Khabbaz, Steven Yakubov, Jae K. Oh, Michael J. Reardon
Journal: Journal of the American College of Cardiology (2015)
TCT-545 Coronary artery vessel healing pattern short term and long term after implantation of the Everolimus-Eluting Bioresorbable Vascular Scaffold
Authors: Robin Kraak, Hans H. de Boer, Joëlle Elias, C.A. Ambarus, Allard C. van der Wal, Robbert J. de Winter, Joanna J. Wykrzykowska
Journal: Journal of the American College of Cardiology (2015)
The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis
Authors: Claudia Günther, Gui-Wei He, Andreas E. Kremer, James M. Murphy, Emma J. Petrie, Kerstin Amann, Peter Vandenabeele, Andreas Linkermann, Christopher Poremba, Ulrike Schleicher, Christin Dewitz, Stefan Krautwald, Markus F. Neurath, Christoph Becker, Stefan Wirtz
Journal: Journal of Clinical Investigation (2016)

Although necrosis and necroinflammation are central features of many liver diseases, the role of programmed necrosis in the context of inflammation-dependent hepatocellular death remains to be fully determined. Here, we have demonstrated that the pseudokinase mixed lineage kinase domain-like protein (MLKL), which plays a key role in the execution of receptor-interacting protein (RIP) kinase-dependent necroptosis, is upregulated and activated in human autoimmune hepatitis and in a murine model of inflammation-dependent hepatitis. Using genetic and pharmacologic approaches, we determined that hepatocellular necrosis in experimental hepatitis is driven by an MLKL-dependent pathway that occurs independently of RIPK3. Moreover, we have provided evidence that the cytotoxic activity of the proinflammatory cytokine IFN-γ in hepatic inflammation is strongly connected to induction of MLKL expression via activation of the transcription factor STAT1. In summary, our results reveal a pathway for MLKL-dependent programmed necrosis that is executed in the absence of RIPK3 and potentially drives the pathogenesis of severe liver diseases.
Synovial sarcoma: A retrospective analyis of 250 patients treated in a single institution
Authors: E. Palmerini, E. L. Staals, L. Zanella, G. Gamberi, L. Pazzaglia, C. Ferrari, A. Longhi, M. Alberghini, M. Mercuri, S. Ferrari
Journal: Journal of Clinical Oncology (2008)

10506 Background: The optimal treatment for synovial sarcoma (SS) is controversial. The present study examines treatment, outcome and prognostic factors in patients treated in a single institution. Methods: SS patients who underwent surgery at the Rizzoli Institute between 1976 and 2006 were identified. Clinical charts and pathology reports were examined. Results: The study included 250 patients (128 female and 122 male); median age was 37 years (range 7–83); 177 (71%) had tumors in the lower limb, 40 (16%) in the upper limb, 33 in the trunk (13%). Size of the lesion was > 5 cm in 121 patients (55%). 204 (82%) patients had localized disease and 46 (18%) were metastatic at presentation. All patients with localized disease underwent surgery, whereas 5 metastatic patients had no excision of the primary lesion. 59 (24%) patients were amputated; the remaining had conservative surgery. Adequate surgical margins were achieved in 211 (88%) patients. Radiotherapy (RT) was added in 117 (49%) patients. Ifosfamide and/or doxorubicin-based chemotherapy was administered to 124 (52%) patients. With a median follow-up of 5 and a half years (1–30 yrs), the 5-year overall survival (OS) was 68%: 10% for metastatic and 76% for localized patients (p=0.0001). The 5-year disease-free survival (DFS) was 58% in localized patients. Size (≤ 5 cm 65% vs. > 5 cm 48%, p = 0.007), age (pediatric 80% vs. adult 55% vs. elderly 68%, p = 0.06), and histology (biphasic 67% vs. monophasic/poorly differentiated 51%, p = 0.08) influenced the 5-year DFS, whereas sex, site, type of surgery, margins and use of RT or chemotherapy did not. After multivariate analysis, together with age, size and histology, the use of RT turned out to be a statistically significant independent factor improving DFS, whereas the use of chemotherapy did not. Conclusions: Patients with metastatic SS at presentation have a poor prognosis. In those with localized disease a good rate of cure can be achieved. Age, size, histology and use RT influence prognosis, whereas the chemotherapy role has to be proven. No significant financial relationships to disclose.
TCT-618 Outcomes of TAVR in Nonagenarians in the U.S.: Insights from the STS/ACC TVT Registry
Authors: Molly Szerlip, Mani Arsalan, Elizabeth M. Holper, Suzanne V. Arnold, Sreekanth Vemulapalli, John S. Rumsfeld, David Brown, Zhuokai Li, Michael Mack
Journal: Journal of the American College of Cardiology (2015)
Diabetes and mortality in men with locally advanced prostate cancer: analyses of RTOG 92–02
Authors: M. R. Smith, B. Kyounghwa, J. A. Efstathiou, G. E. Hanks, M. V. Pilepich, H. M. Sandler, W. U. Shipley
Journal: Journal of Clinical Oncology (2008)

5013 Background: Diabetes is associated with lower risk of prostate cancer. Most men with diabetes are obese and obesity is associated with greater prostate cancer mortality. Whether diabetes influences outcomes after prostate cancer diagnosis is unknown. Methods: We assessed the relationship between prevalent diabetes and mortality using data from RTOG 92–02, a large randomized trial of men (n=1,554) treated with radiation therapy and short-term versus long-term adjuvant goserelin for locally advanced prostate cancer. Cox regression and Fine and Gray’s proportional hazard models were performed to evaluate relationship between prevalent diabetes and all- cause mortality, prostate cancer mortality, and non-prostate cancer mortality. Covariates included age, race, tumor stage, Gleason score, PSA, prevalent diabetes, weight, and treatment arm. Results: There were at total of 765 deaths; 210 (27%) were attributed to prostate cancer. In univariate analyses, prevalent diabetes was associated with greater all-cause mortality and non-prostate cancer mortality but not prostate cancer mortality. After controlling for other covariates, prevalent diabetes remained significantly associated with greater all-cause mortality and non-prostate cancer mortality (hazard ratio (HR) 2.12; 95% CI 1.69–2.66, p<0.0001) but not prostate cancer mortality (HR 0.80; 95% CI 0.51–1.25, p=0.34). In contrast, weight was associated with greater prostate cancer mortality (HR 1.77; 95% CI 1.22–2.55, p=0.002) but not all-cause or non-prostate cancer mortality. Conclusions: Weight but not prevalent diabetes is associated with greater prostate cancer mortality in men receiving combined modality treatment for locally advanced disease. These observations suggest that the association between obesity and greater prostate cancer mortality is mediated by mechanism(s) other than insulin resistance. No significant financial relationships to disclose.
High Incidence of Venous Thromboembolism in Patients with Lymphoma Receiving Chemotherapy: Assessment of Risk Factors.
Authors: Shyam Teegala, Xiao Zhou, Auris Huen, Yuan Ji, Luis Fayad, Jorge Enrique Romaguera, F.B. Hagemeister, Saroj Vadhan-Raj
Journal: Blood (2006)
TCT-259 Impact of ECG-Defined Infarct Location on Mortality in Patients with STEMI Undergoing Primary PCI: Insights from the HORIZONS-AMI Trial
Authors: Gennaro Giustino, Joe Dizon, Philippe Genereux, Roxana Mehran, Mario Gössl, Bernard j Gersh, Girma M. Ayele, Gregg W. Stone
Journal: Journal of the American College of Cardiology (2015)
Association of a Pro-Inflammatory Axis Comprised By TSP1-TGF-CTGF/CCN2 with a Decrease in Mir-19a-3p in the Pathophysiology of Diabetic Retinopathy
Authors: Philippe Alexander Alvarez Dela Cadena, Jose Francisco Calva Moreno, Fabiola Elizabeth Del Carpio-Cano, Rao Ajaykumar, William J Foster, Raul A Dela Cadena
Journal: Blood (2015)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Authors: Julian P T Higgins, Karla Soares-Weiser, José A López-López, Artemisia Kakourou, Katherine Chaplin, Hannah Christensen, Natasha K Martin, Jonathan A C Sterne, Arthur L Reingold
Journal: BMJ (2016)

<b>Objectives</b>&nbsp;To evaluate the effects on non-specific and all cause mortality, in children under 5, of Bacillus Calmette-Guérin (BCG), diphtheria-tetanus-pertussis (DTP), and standard titre measles containing vaccines (MCV); to examine internal validity of the studies; and to examine any modifying effects of sex, age, vaccine sequence, and co-administration of vitamin A. <b>Design</b>&nbsp;Systematic review, including assessment of risk of bias, and meta-analyses of similar studies. <b>Study eligibility criteria</b>&nbsp;Clinical trials, cohort studies, and case-control studies of the effects on mortality of BCG, whole cell DTP, and standard titre MCV in children under 5. <b>Data sources</b>&nbsp;Searches of Medline, Embase, Global Index Medicus, and the WHO International Clinical Trials Registry Platform, supplemented by contact with experts in the field. To avoid overlap in children studied across the included articles, findings from non-overlapping birth cohorts were identified. <b>Results</b>&nbsp;Results from 34 birth cohorts were identified. Most evidence was from observational studies, with some from short term clinical trials. Most studies reported on all cause (rather than non-specific) mortality. Receipt of BCG vaccine was associated with a reduction in all cause mortality: the average relative risks were 0.70 (95% confidence interval 0.49 to 1.01) from five clinical trials and 0.47 (0.32 to 0.69) from nine observational studies at high risk of bias. Receipt of DTP (almost always with oral polio vaccine) was associated with a possible increase in all cause mortality on average (relative risk 1.38, 0.92 to 2.08) from 10 studies at high risk of bias; this effect seemed stronger in girls than in boys. Receipt of standard titre MCV was associated with a reduction in all cause mortality (relative risks 0.74 (0.51 to 1.07) from four clinical trials and 0.51 (0.42 to 0.63) from 18 observational studies at high risk of bias); this effect seemed stronger in girls than in boys. Seven observational studies, assessed as being at high risk of bias, have compared sequences of vaccines; results of a subset of these suggest that administering DTP with or after MCV may be associated with higher mortality than administering it before MCV. <b>Conclusions</b>&nbsp;Evidence suggests that receipt of BCG and MCV reduce overall mortality by more than would be expected through their effects on the diseases they prevent, and receipt of DTP may be associated with an increase in all cause mortality. Although efforts should be made to ensure that all children are immunised on schedule with BCG, DTP, and MCV, randomised trials are needed to compare the effects of different sequences.
GW27-e0263 A study on the mechanism of the eNOS/NO system in Ginsenoside Rb1 against the replicative senescence of endothelial cells
Authors: Bin Zhou, Min Wang, Dinghui Liu, Shujie Yu, Lin Wu, Yong Liu, Baoshun Hao, Lin Chen, Xiaoxian Qian
Journal: Journal of the American College of Cardiology (2016)
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
Authors: Pinar Kanlikilicer, Mohammed H. Rashed, Recep Bayraktar, Rahul Mitra, Cristina Ivan, Burcu Aslan, Xinna Zhang, Justyna Filant, Andreia M. Silva, Cristian Rodriguez-Aguayo, Emine Bayraktar, Martin Pichler, Bulent Ozpolat, George A. Calin, Anil K. Sood, Gabriel Lopez-Berestein
Journal: Cancer Research (2016)

Abstract Cancer cells actively promote their tumorigenic behavior by reprogramming gene expression. Loading intraluminal vesicles with specific miRNAs and releasing them into the tumor microenvironment as exosomes is one mechanism of reprogramming whose regulation remains to be elucidated. Here, we report that miR-6126 is ubiquitously released in high abundance from both chemosensitive and chemoresistant ovarian cancer cells via exosomes. Overexpression of miR-6126 was confirmed in healthy ovarian tissue compared with ovarian cancer patient samples and correlated with better overall survival in patients with high-grade serous ovarian cancer. miR-6126 acted as a tumor suppressor by directly targeting integrin-β1, a key regulator of cancer cell metastasis. miR-6126 mimic treatment of cancer cells resulted in increased miR-6126 and decreased integrin-β1 mRNA levels in the exosome. Functional analysis showed that treatment of endothelial cells with miR-6126 mimic significantly reduced tube formation as well as invasion and migration capacities of ovarian cancer cells in vitro. Administration of miR-6126 mimic in an orthotopic mouse model of ovarian cancer elicited a relative reduction in tumor growth, proliferating cells, and microvessel density. miR-6126 inhibition promoted oncogenic behavior by leading ovarian cancer cells to release more exosomes. Our findings provide new insights into the role of exosomal miRNA-mediated tumor progression and suggest a new therapeutic approach to disrupt oncogenic phenotypes in tumors. Cancer Res; 76(24); 7194–207. ©2016 AACR.
Ethical Considerations in the Development of the Flexibility in Duty Hour Requirements for Surgical Trainees Trial
Authors: Christina A. Minami, David D. Odell, Karl Y. Bilimoria
Journal: JAMA Surgery (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
GW27-e0575 Impact of Renal Impairment on Platelet Reactivity and Clinical Outcomes During Chronic Dual Antiplatelet Therapy Following Coronary Stenting
Authors: Moo Hyun Kim, Long Zhe Guo, Chang Heon Shim, Sun Young Choi, Victor L. Serebruany
Journal: Journal of the American College of Cardiology (2016)
TCT-672 Comparison of Feasibility and Efficacy of Transcatheter Aortic Valve Implantation Between Patients Aged ≤75 years and Those &gt;75 years
Authors: Takahide Arai, Bernard Chevalier, Thomas Hovasse, Kentaro Hayashida, Yusuke Watanabe, Stephen O'Connor, Mauro Romano, Philippe Garot, Hakim Benamer, Thierry Unterseeh, Erik Bouvier, Marie-Claude Morice, Thierry Lefevre
Journal: Journal of the American College of Cardiology (2015)
TCT-728 Cost-Effectiveness of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation and Contraindications to Oral Anticoagulation
Authors: Jacqueline Saw, Maria C. Bennell, Sheldon M. Singh, Harindra C. Wijeysundera
Journal: Journal of the American College of Cardiology (2015)
ICOS Gene Polymorphisms In B-Cell Chronic Lymphocytic Leukemia In a Polish Population.
Authors: Irena Frydecka, Lidia Karabon, Anna Jedynak, Anna Tomkiewicz, Edyta Pawlak, Dariusz Wolowiec, Marek Kielbinski, Kazimierz Kuliczkowski, Dariusz Woszczyk, Tomasz Wrobel
Journal: Blood (2010)
Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association
Authors: Walter R. Wilson, Thomas C. Bower, Mark A. Creager, Sepideh Amin-Hanjani, Patrick T. O’Gara, Peter B. Lockhart, Rabih O. Darouiche, Basel Ramlawi, Colin P. Derdeyn, Ann F. Bolger, Matthew E. Levison, Kathryn A. Taubert, Robert S. Baltimore, Larry M. Baddour
Journal: Circulation (2016)

BackgroundThe use of synthetic material for reconstructive vascular surgery was first reported during the early 1950s.Infection involving vascular graft prostheses is an infrequent but devastating complication of reconstructive vascular graft surgery and is associated with a high morbidity and, in some situations, mortality.Improvements in surgical techniques and graft design, including the use of native venous or arterial tissue, have reduced the frequency of infection and severity of complications from vascular graft infection (VGI).However, these advances have also led to more frequent vascular graft procedures occurring in a patient population with multiple underlying comorbidities that would have previously disqualified them as candidates for vascular reconstructive surgery.Underlying comorbidities, such as diabetes mellitus or immune compromise, increase the risk of infection and serious infection-related complications.The major complications of VGI include sepsis, amputation, disruption of infected anastomotic suture line with rupture or pseudoaneurysm formation, embolization of infected thrombi, reinfection of reconstructed vascular grafts, enteric fistulae to the small or large bowel, bacteremic spread of infection to other sites, and death.VGIs can be categorized broadly into those that occur in an extracavitary location, primarily in the groin or lower extremities, or in an intracavitary location, primarily within the abdomen or less commonly within the thorax. frequencyThe frequency of VGI depends on the anatomic location of the graft.][4]10 Aortic graft erosion or fistulous communication into the duodenum or other areas of the bowel reportedly occurs in 1% to 2% of patients after aortic reconstruction. 11,12 MicrobiologyThe microbiological cause of VGI has evolved over the years. 1 In early published studies, Staphylococcus aureus was the predominant microorganism recovered. 1,13mprovements in surgical technique, administration of prophylactic antistaphylococcal antimicrobial therapy, and other factors have resulted in a changing microbiological epidemiology.Vascular graft surgery performed on patients with multiple underlying comorbidities and the increased frequency of emergency procedures have contributed to the changing spectrum of infection.Other factors such as changes in hospital flora, surgery in patients with complicated vascular anatomy, and multiple revisions of previous vascular surgery have resulted in a more diverse microbio-
Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
Authors: Rituparna Das, Till Strowig, Rakesh Verma, Srinivas Koduru, Anja Hafemann, Stephanie Hopf, Mehmet H Kocoglu, Chiara Borsotti, Lin Zhang, Andrew Branagan, Elizabeth Eynon, Markus G Manz, Richard A Flavell, Madhav V Dhodapkar
Journal: Nature Medicine (2016)
Clinical Profile and Outcome Of Patients With Graft Rejection Following Related HLA Matched Allogeneic Stem Cell Transplant For β Thalassemia Major
Authors: Vikram Mathews, Abhijeet Ganapule, Biju George, Kavitha M Lakshmi, Aby Abraham, Auro Viswabandya, Alok Srivastava
Journal: Blood (2013)
The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)
Authors: Aziz Nazha, Sudipto Mukherjee, Ramon V. Tiu, Yogen Saunthararajah, Michael K. Keng, David J. Seastone, Sean Hobson, Anjali S. Advani, Jaroslaw P. Maciejewski, Mikkael A. Sekeres
Journal: Blood (2013)
GW27-e0597 Enhanced external counterpulsation promotes reendothelialization capacity of endothelial progenitor cells via activation of Tie2-dependent signaling pathway in stable angina patients
Authors: Jia Xu, Jinli Liao, Yan Xiong, Feng Zhu, Ziyu Zheng, Hong Zhan
Journal: Journal of the American College of Cardiology (2016)